TuHURA Biosciences Stock (NASDAQ:HURA)
Previous Close
$2.85
52W Range
$1.80 - $8.64
50D Avg
$2.75
200D Avg
$3.93
Market Cap
$129.41M
Avg Vol (3M)
$263.68K
Beta
0.17
Div Yield
-
HURA Company Profile
TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.